Literature DB >> 33737379

Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?

Sagal Mohamed1, Claudio U Köser2, Max Salfinger3, Wladimir Sougakoff4, Scott K Heysell1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33737379      PMCID： PMC8920038          DOI： 10.1183/13993003.04077-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  29 in total

1.  Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland.

Authors:  Elisabeth Sanchez-Padilla; Matthias Merker; Patrick Beckert; Frauke Jochims; Themba Dlamini; Patricia Kahn; Maryline Bonnet; Stefan Niemann
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

2.  Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays.

Authors:  S V Omar; D Hillemann; S Pandey; M Merker; A-K Witt; D Nadarajan; I Barilar; A Bainomugisa; E C Kelly; R Diel; D S Vidanagama; A I P Samarasinghe; M R Cader; U Götsch; E Lavu; A Alabi; T Schön; C Coulter; S Niemann; F P Maurer; N A Ismail; C U Köser; F Ismail
Journal:  Int J Tuberc Lung Dis       Date:  2020-12-01       Impact factor: 2.373

Review 3.  Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing.

Authors:  T M Walker; P Monk; E Grace Smith; T E A Peto
Journal:  Clin Microbiol Infect       Date:  2013-02-21       Impact factor: 8.067

Review 4.  Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases.

Authors:  Niaz Banaei; Kimberlee A Musser; Max Salfinger; Akos Somoskovi; Adrian M Zelazny
Journal:  Clin Lab Med       Date:  2020-10-06       Impact factor: 1.935

5.  Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.

Authors:  Lakshmi Soundararajan; Priti Kambli; Sushri Priyadarshini; Biswajit Let; Sakthivel Murugan; Chitra Iravatham; Jeffrey A Tornheim; Camilla Rodrigues; Ravi Gupta; V L Ramprasad
Journal:  Tuberculosis (Edinb)       Date:  2020-02-20       Impact factor: 3.131

6.  Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species.

Authors:  Enrico Tortoli; Monica Pecorari; Giuliana Fabio; Massimino Messinò; Anna Fabio
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

7.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

Review 8.  Routine use of microbial whole genome sequencing in diagnostic and public health microbiology.

Authors:  Claudio U Köser; Matthew J Ellington; Edward J P Cartwright; Stephen H Gillespie; Nicholas M Brown; Mark Farrington; Matthew T G Holden; Gordon Dougan; Stephen D Bentley; Julian Parkhill; Sharon J Peacock
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

9.  How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide.

Authors:  Claudio U Köser; Daniela M Cirillo; Paolo Miotto
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

10.  Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

Authors:  Elisa Tagliani; Mohamed Osman Hassan; Yacine Waberi; Maria Rosaria De Filippo; Dennis Falzon; Anna Dean; Matteo Zignol; Philip Supply; Mohamed Ali Abdoulkader; Hawa Hassangue; Daniela Maria Cirillo
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379
View more
  4 in total

1.  On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex.

Authors:  Claudio U Köser; Sophia B Georghiou; Thomas Schön; Max Salfinger
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.

Authors:  Roger Vargas; Luca Freschi; Andrea Spitaleri; Sabira Tahseen; Ivan Barilar; Stefan Niemann; Paolo Miotto; Daniela Maria Cirillo; Claudio U Köser; Maha R Farhat
Journal:  Antimicrob Agents Chemother       Date:  2021-08-30       Impact factor: 5.938

3.  The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.

Authors:  Timothy M Walker; Paolo Miotto; Claudio U Köser; Derrick W Crook; Nazir Ismail; Timothy C Rodwell; Philip W Fowler; Jeff Knaggs; Zamin Iqbal; Martin Hunt; Leonid Chindelevitch; Maha Farhat; Daniela Maria Cirillo; Iñaki Comas; James Posey; Shaheed V Omar; Timothy Ea Peto; Anita Suresh; Swapna Uplekar; Sacha Laurent; Rebecca E Colman; Carl-Michael Nathanson; Matteo Zignol; Ann Sarah Walker
Journal:  Lancet Microbe       Date:  2022-04

4.  Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Authors: 
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.